Sonus looks for EchoGen distributor as Abbott ends link
This article was originally published in Clinica
Executive Summary
Abbott has terminated the US marketing agreement with Sonus Pharmaceuticals for the development stage company's EchoGen ultrasound contrast imaging agent. This leaves Sonus looking for a salesforce for the product. It was announced in February they were renegotiating their agreement.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.